Apogee Therapeutics APGE 深 滬
等待開盤 10-21 09:30:00 美东时间
56.94
+1.790
+3.25%
華盛通- 最 高57.03
- 今 開55.69
- 成交量 83.05万股
- 最 低 55.08
- 昨 收 55.15
- 總市值 33.93亿
- 52周最高 63.50
- 市盈率 靜 --
- 換手率 1.39%
- 52周最低 26.20
- 委 比 -80.82%
- 總股本 5959.64万
- 歷史最高 72.29
- 量 比 0.85
- 振 幅 3.54%
- 歷史最低 14.19
- 每 手 1
- 風險率 6.32%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $345 Million
Apogee Therapeutics完成8,048,782股普通股的公开募股，每股41美元，总募股额约3.45亿美元。此外，提供365,853股预资助认股权证，总价值约1480万美元，总募资约3.45亿美元。公司专注于炎症和免疫学市场的生物制剂开发，旨在最佳治疗如湿疹、哮喘等疾病。
10-10 20:01
美股大行评级 | 潜在涨幅334.0%！HC Wainwright & Co.上调Inventiva目标价至24美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Inventiva"买入"评级，目标价从20美元升至24美元；摩根大通：维持BioMarin Pharmaceutical"超配"评级，目标价从116美元升至119美元
10-10 11:36
BTIG Reiterates Buy on Apogee Therapeutics, Maintains $115 Price Target
BTIG analyst Julian Harrison reiterates Apogee Therapeutics (NASDAQ:APGE) with a Buy and maintains $115 price target.
10-09 22:53
美联储降息再迎大消息，纳指生科创年内新高，纳指生物科技ETF(513290)强势收涨6.22%，连续16日获资金加仓，“吸金”近7300万元
隔夜（10月8日）美股收盘，美股三大指数涨跌不一，纳指涨1.12%，标普500指数涨0.58%，两者均创收盘新高，道指收平。纳斯达克生物科技指数收涨0.89%...
10-09 17:58
Biggest stock movers Thursday: AZZ, RELL, and more
Stock futures were largely unchanged in premarket trading on Thursday, following a strong tech rally that pushed the Nasdaq to a new record high in the previous session. Here are some of Thursday's bi...
10-09 17:00
Apogee Therapeutics prices $300M public offering
Apogee Therapeutics (NASDAQ:APGE) priced its public offering at $41 per share, raising ~$300M in gross proceeds. The offering includes 6.95M common shares and 365,853 pre-funded warrants priced at $41...
10-09 14:18
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Adaptimmune Therapeutics (NASDAQ:ADAP) stock moved upwards by 32.1% to...
10-09 05:06
Apogee Therapeutics shares are trading lower after the company announced a proposed underwritten public offering.
Apogee Therapeutics shares are trading lower after the company announced a prop...
10-09 04:07
Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
Apogee Therapeutics_initiating a public stock offering with an option to sell up to 15% additional shares. Proceeds will support preclinical and clinical efforts in immunology and inflammatory diseases, including Atopic Dermatitis and asthma. The offering is led by Jefferies, BofA Securities, and other financial institutions.
10-08 20:01
